Core Laboratories (CLB) Change in Account Payables (2022 - 2026)

Core Laboratories has reported Change in Account Payables for 5 years, with the latest figure at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables fell 4.17% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $353000.0 (down 91.26% YoY), and the FY2025 full-year result was $477000.0, down 8.09% from the prior year.
• Change in Account Payables for Q1 2026 stood at $2.8 million, up from -$807000.0 in the prior quarter.
• The five-year high for Change in Account Payables was $11.1 million in Q4 2022, with the low at -$7.1 million in Q1 2023.
• Historically, Change in Account Payables has averaged $85133.3 across 5 years, with a median of -$551000.0 in 2024.
• Annual changes were most pronounced in 2023 — Change in Account Payables plunged 470.54% — and 2025, when it soared 639.2%.
• Core Laboratories' Change in Account Payables stood at $11.1 million in 2022, then plunged by 97.99% to $223000.0 in 2023, then jumped by 300.0% to $892000.0 in 2024, then plunged by 190.47% to -$807000.0 in 2025, then jumped by 452.79% to $2.8 million in 2026.
• The last three Change in Account Payables figures came in at $2.8 million (Q1 2026), -$807000.0 (Q4 2025), and -$5.4 million (Q3 2025), per Business Quant data.